Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001129928-17-000003
Filing Date
2017-03-28
Accepted
2017-03-27 18:52:03
Documents
18
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 20-F oncyf2016-20f.htm 20-F 1664344
2 EXHIBIT 4.39 GUTTIERREZ ex439guttierrez.htm EX-4.39 77947
3 EXHIBIT 4.40 COFFEY ex440coffey.htm EX-4.40 18321
4 EXHIBIT 4.41 LOOK ex441look.htm EX-4.41 15350
5 EXHIBIT 4.42 THOMPSON ex442thompson.htm EX-4.42 54466
6 EXHIBIT 8.0 SUBSIDIARIES ex80subsidiaries.htm EX-8.0 3758
7 EXHIBIT 12.1 CEO CERTIFICATION ex121ceocertfication2016.htm EX-12.1 13553
8 EXHIBIT 12.2 CFO CERTIFICATION ex122cfocertification2016.htm EX-12.2 12663
9 EXHIBIT 13.1 CEO CERTIFICATION ex131ceocertification2016.htm EX-13.1 7107
10 EXHIBIT 13.2 CFO CERTIFICATION ex132cfocertification2016.htm EX-13.2 5947
11 EXHIBIT 15.1 MD&A ex151-2016mda.htm EX-15.1 437700
12 EXHIBIT 15.2 AUDITOR CONSENT ex152eyconsentletter2016.htm EX-15.2 4720
13 eysig1.jpg GRAPHIC 6545
14 fig2.jpg GRAPHIC 239003
15 figure1a04.jpg GRAPHIC 285168
16 image3a01.jpg GRAPHIC 6545
17 logo1.jpg GRAPHIC 32654
18 optiontable.jpg GRAPHIC 134318
  Complete submission text file 0001129928-17-000003.txt   3287276
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 000-31062 | Film No.: 17716446
SIC: 2834 Pharmaceutical Preparations